Author:
van der Werf Tjip S.,Phillips Richard O.,Johnson Roch C.,Barogui Yves T.
Publisher
Springer International Publishing
Reference96 articles.
1. Buckle G, Tolhurst JC. A new mycobacterial infection in man; cultivation of the new Mycobacterial infection in man; cultivation of the new Mycobacterium. J Pathol Bacteriol. 1948;60(1):116–22.
2. Portaels F, Traore H, De Ridder K, Meyers WM. In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. Antimicrob Agents Chemother. 1998;42(8):2070–20703. https://doi.org/10.1128/AAC.42.8.2070.
3. Thangaraj HS, Adjei O, Allen BW, Portaels F, Evans MR, Banerjee DK, et al. In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans. J Antimicrob Chemother. 2000;45(2):231–3. https://doi.org/10.1093/jac/45.2.231.
4. Feldman WH, Karlson AG. Mycobacterium ulcerans infections; response to chemotherapy in mice. Am Rev Tuberc. 1957;75(2):266–79. https://doi.org/10.1164/artpd.1957.75.2.266.
5. Dega H, Robert J, Bonnafous P, Jarlier V, Grosset J. Activities of several antimicrobials against Mycobacterium ulcerans infection in mice. Antimicrob Agents Chemother. 2000;44(9):2367–72. https://doi.org/10.1128/aac.9.2367-2372.2000.